FIELD: chemistry.
SUBSTANCE: invention relates to a method for the production of a polymorphous form B of Treprostinil diethanolamine salt, including following stages: a. dissolution of Treprostinil in methanol at 25-50°C, b. addition to the solution obtained at the stage a) of diethanolamine or its solution in methanol, c. mixing of the reaction mixture obtained at the stage b) until its complete dissolution, d. after the completion of salt formation at the stage c), addition to the solution of the first portion of an aprotic solvent, e. filtration of the solution obtained at the stage d), f. introduction to the filtrate obtained at the stage e) of a seed from the polymorphous form B of Treprostinil diethanolamine salt, g. addition to the suspension of crystals obtained at the stage f) of the second portion of the aprotic solvent, h. mixing of the suspension obtained at the stage g) until crystallization completion, i. isolation, flushing, and drying of crystals, where the aprotic solvent is selected from esters, ketones, composite esters, and acetonitrile. The invention also relates to the conversion of a polymorphous form A or a mixture of polymorphous forms A and B of Treprostinil diethanolamine salt into a polymorphous form B.
EFFECT: new stable reproducible method for the production of a polymorphous form B of Treprostinil diethanolamine salt is developed.
9 cl, 2 tbl, 17 ex, 21 dwg
Title |
Year |
Author |
Number |
4-[2-[[5-METHYL-1-(2-NAPHTHALINYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE HYDROCHLORIDE POLYMORPH AND SOLVATES |
2011 |
- Berenger Majmo Ramon
- Medrano Ruperes Khorkhe
- Benet Bukhkhol'Ts Khordi
- Puig Fernandes Laura
- Pellekha Pukseu Laja
|
RU2560150C2 |
SOLID FORMS OF (1,1-DIOXO-4-THIOMORPHOLINYL) - [6 - [[3- (4-FLUOROPHENYL) -5-METHYL-4-ISOXAZOLYL] METHOXY] -3-PYRIDINYL] METHANONE |
2012 |
- Dott Paskal
- Grassmann Olaf
- Kammerer Mikhel
- Manns Ioakhim
- Shvitter Urs
- Tomas Endryu
- Vittenbakh Nikol
|
RU2618524C2 |
POLYMORPHIC FORMS OF MACROCYCLIC HCV INHIBITOR |
2008 |
- Stokbruks Sigrid Karl Marija
- Lejs Karina
- Suinni Kelli Ehnn
- Vujts Stejn
- Khorvat Andrash
|
RU2533830C2 |
METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3-CYANOBENZOYL)PYRAZOLE-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE |
2017 |
- Suleiman, Osama
- Perez, Lucia Romero
- Harlacher, Cornelius Stephan
- Jones, Stewart
|
RU2792728C2 |
METHOD FOR PRODUCING POLYMORPH FORM OF 3-[5-AMINO-4-(3-CYANOBENZOYL)PYRAZOLE-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE |
2017 |
- Suleiman, Osama
- Perez, Lucia Romero
- Harlacher, Cornelius Stephan
- Jones, Stewart
|
RU2765719C2 |
HIGHLY PURE PENTAMYCIN |
2009 |
- Rojter Karl
- Majer Viktor
- Shtol'Ts Florian
- Krimmer Diter
- Vinninps Ses
|
RU2515936C2 |
PHENYL AMINO PYRIMIDINE COMPOUND OR POLYMORPH OF SALT THEREOF |
2016 |
- Lyuj Binkhua
- Li Chenvej
- Syao Dan
|
RU2712226C2 |
POLYMORPHS OF DEUTERATED OMEGA-DIPHENYLUREA OR SALTS THEREOF |
2013 |
|
RU2600929C2 |
SOLID FORMS |
2007 |
- B'Juchemps Mari G.
- Khilgraf Robert
- Kotare Mokhit Atul
- Kameron Luiz Mishel
- Sejndejn Monokhar T.
- Sjuj Dzhin
|
RU2496780C2 |
POLYMORPHIC MODIFICATION IN N-{5-[3-(THIOPHENE-2-CARBONYL)-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL]-2-FLUORO-PHENYL}-N-METHYL-ACETAMIDE (VERSIONS), CONTAINING IT PHARMACEUTICAL COMPOSITION (VERSIONS), MEDICATION, METHOD OF OBTAINING SAID POLYMORPHIC MODIFICATION (VERSIONS) AND METHOD OF TREATMENT AND/OR PREVENTION OF NERVOUS DISORDERS |
2007 |
- Anglada Luis
- Gul'Etta Antonio
- Palomer Al'Bert
|
RU2413729C2 |